Eugene Becker, MD
Pain Medicine · Marion, ILNPI 1871532317
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,591 of the $8,036 with a category attached, or 69.6%. Boston Scientific accounts for 74.0% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2023 at $3,332 and has fallen 62.1% since, to $1,265 in 2024.
Across 185 payments — averaging $43.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$6K
- Pacira Pharmaceuticals Incorporated$948
- AbbVie$238
- Baudax Bio Inc.$178
- Nevro Corp.$170
- Avanos Medical$98
- plus $460 from 13 others
What the payments were for
- Travel & lodging$2,44530%
- Food & beverage$5,59170%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 129 | $5,944 |
| Pacira Pharmaceuticals Incorporated | 6 | $948 |
| AbbVie(2 entities) | 12 | $238 |
| Baudax Bio Inc. | 9 | $178 |
| Nevro Corp. | 3 | $170 |
| Avanos Medical | 2 | $98 |
| Redhill Biopharma Inc. | 3 | $69 |
| SPR Therapeutics, Inc | 1 | $65 |
| Amgen | 4 | $59 |
| Biodelivery Sciences International, Inc. | 4 | $59 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $57 |
| Kowa Pharmaceuticals America, Inc. | 2 | $29 |
| Stimwave Technologies Incorporated | 1 | $21 |
| Pfizer | 1 | $20 |
| Sun Pharmaceutical Industries Inc. | 1 | $20 |
| IBSA Pharma Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $16 |
| Abbott | 1 | $16 |
| Providence Medical Technology, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Iovera$839
- WaveWriter Alpha Prime 16$666
- SUPERION$228
- CoverEdge 32$138
- GENERAL PAIN MANAGEMENT$123
- WAVEWRITER ALPHA$110
- CLINICAL TRIAL PRODUCT$105
How this compares
$8,036 in reported general payments places this provider in the 75th percentile of 233 pain medicine providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pregabalin | 826 | $23,912 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,273 | $22,946 |
| BelbucaBuprenorphine Hcl | 20 | $20,938 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 727 | $15,676 |
| Buprenorphine | 58 | $14,614 |
| Tizanidine Hcl | 1,308 | $12,567 |
| Gabapentin | 691 | $9,286 |
| OxycontinOxycodone Hcl | 21 | $9,148 |
| Tramadol Hcl | 989 | $7,588 |
| MovantikNaloxegol Oxalate | 14 | $5,905 |
| Duloxetine Hcl | 340 | $4,077 |
| Baclofen | 231 | $2,532 |
| Methocarbamol | 101 | $1,292 |
| Oxycodone Hcl | 107 | $1,291 |
| Buprenorphine Hcl | 58 | $1,245 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Redhill Biopharma Inc.Movantik | $69 | $5,90514 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 233 pain medicine providers in Illinois.
Other pain medicine in Marion
- Ricardo VallejoBloomington$2.3M
- David DickersonEvanston$558K
- Thomas DahlbergRockford$218K
- Steven CohenChicago$217K
- Albert SinghQuincy$212K
- Nirav ShahSkokie$137K
- Ryan KutaNaperville$114K
- Anthony LebarioElgin$87K
- Keith SchmidtHoffman Estates$81K
- Jay HurhLibertyville$71K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.